ERBB2 and neoplasm: For unmodified CD16Hi Vδ2 T cells, against OVCAR3-FG cells, isotype control had minimal impact on Vδ2 T cell cytotoxicity, whereas significant enhancement of tumor killing was seen with concentrations of anti-HER2 mAb as low as 0.1 μg/mL (Fig. 5c).